← Every applicant
Hengrui Pharma FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| PACLITAXELNew drugOct 8, 2024POWDER, INTRAVENOUS |
| BUPIVACAINE LIPOSOMENew drugJul 1, 2024INJECTABLE, LIPOSOMAL, INJECTION |
| GADOBUTROLNew drugSep 8, 2023SOLUTION, INTRAVENOUS |
| GADOBUTROLNew drugNov 17, 2022SOLUTION, INTRAVENOUS |
| IODIXANOLNew drugMay 19, 2022INJECTABLE, INJECTION |
| GADOTERATE MEGLUMINENew drugApr 11, 2022SOLUTION, INTRAVENOUS |
| CARMUSTINENew drugMar 12, 2021INJECTABLE, INJECTION |